A Phase 1, Open-label, Fixed-sequence, 2-cohort, 2-period Study To Investigate The Effect Of Modafinil And Pioglitazone Given As Multiple Doses On Single Dose Pharmacokinetics Of Palbociclib (Pd-0332991) In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Feb 2015
Price : $35 *
At a glance
- Drugs Palbociclib (Primary) ; Modafinil; Pioglitazone
- Indications Breast cancer; Colorectal cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Multiple myeloma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 19 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 10 Sep 2014 Planned initiation date changed from 1 Oct 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.